Health
Semaglutide for Meaningful Weight Loss in Obesity and Diabetes? – Medscape
“This is by far the best result we had with any weight loss medicine in patients with diabetes,” says the senior author of the STEP 2 clinical trial of weekly subcutaneous…
A 2.4-mg weekly injection of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide led to a clinically meaningful 5% loss in weight for roughly two thirds of patients with both overweight/obesity and type 2 diabetes, researchers report.
These findings from the Semaglutide Treatment Effect in People With Obesity 2 (STEP 2) trial, one of four phase 3 trials of this drug, which is currently under regulatory review for weight loss, were published March 2 in The Lancet.
More than 1000 patients…
Continue Reading
